Vici P - Search Results

1

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy.

Vici P, Mottolese M, Pizzuti L, Barba M, Sperati F, Terrenato I, Di Benedetto A, Natoli C, Gamucci T, Angelucci D, Ramieri MT, Di Lauro L, Sergi D, Bartucci M, Dattilo R, Pagliuca A, De Maria R, Maugeri-Saccà M. Vici P, et al. Oncotarget. 2014 Oct 30;5(20):9619-25. doi: 10.18632/oncotarget.2449. Oncotarget. 2014. PMID: 25294813 Free PMC article. Clinical Trial.

2

5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer.

Lopez M, Natali M, Di Lauro L, Tonini G, Carpano S, Vici P, Conti EM. Lopez M, et al. Among authors: vici p. Am J Clin Oncol. 1990 Jun;13(3):204-7. doi: 10.1097/00000421-199006000-00005. Am J Clin Oncol. 1990. PMID: 1693258

3

[Buserelin therapy in postmenopausal patients with advanced breast carcinoma].

Vici P, Veltri E, Carpano S, Di Lauro L, Lopez M. Vici P, et al. Clin Ter. 1991 Feb 15;136(3):195-9. Clin Ter. 1991. PMID: 1827382 Italian.

4

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.

Lopez M, Vici P, Carpano S, Natali M, Ganzina F, Conti EM, Di Lauro L. Lopez M, et al. Among authors: vici p. J Cancer Res Clin Oncol. 1991;117(1):61-4. doi: 10.1007/BF01613198. J Cancer Res Clin Oncol. 1991. PMID: 1997473 Clinical Trial.

5

Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.

Lopez M, Carpano S, Di Lauro L, Vici P, Conti EM. Lopez M, et al. Among authors: vici p. Oncology. 1991;48(3):230-3. doi: 10.1159/000226933. Oncology. 1991. PMID: 2023703 Clinical Trial.

6

5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer.

Lopez M, Papaldo P, Di Lauro L, Vici P, Carpano S, Conti EM. Lopez M, et al. Among authors: vici p. Oncology. 1989;46(1):1-5. doi: 10.1159/000226671. Oncology. 1989. PMID: 2915887 Clinical Trial.

7

Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer.

Lopez M, Vici P, Di Lauro L, Paoletti G, Gionfra T, Conti F, Carpano S, Pignatti F, Giannarelli D. Lopez M, et al. Among authors: vici p. Eur J Cancer. 1995 Sep;31A(10):1611-4. doi: 10.1016/0959-8049(95)00200-3. Eur J Cancer. 1995. PMID: 7488410 Clinical Trial.

8

Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.

Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R. Botti C, et al. Among authors: vici p. J Am Coll Surg. 1995 Sep;181(3):202-8. J Am Coll Surg. 1995. PMID: 7670678

9

Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer.

Di Lauro L, Del Medico P, Carpano S, Cancrini A, Gionfra T, Vici P, Rosselli M, Lopez M. Di Lauro L, et al. Among authors: vici p. Tumori. 1995 Jan-Feb;81(1):42-4. doi: 10.1177/030089169508100110. Tumori. 1995. PMID: 7754540 Clinical Trial.

10

Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects.

Lopez M, Carpano S, Cavaliere R, Di Lauro L, Ameglio F, Vitelli G, Frasca AM, Vici P, Pignatti F, Rosselli M, et al. Lopez M, et al. Among authors: vici p. Ann Oncol. 1994 Oct;5(8):741-6. doi: 10.1093/oxfordjournals.annonc.a058979. Ann Oncol. 1994. PMID: 7826907 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters